Cerebral Palsy in Older Children: Clinical Signs
In school-age children with cerebral palsy, look for persistent primitive reflexes, spasticity with increased tone and hyperreflexia, abnormal gait patterns (toe-walking, scissoring), and motor type classification (spastic 85-91%, dyskinetic 4-7%, ataxic 4-6%, hypotonic 2%) along with common comorbidities including chronic pain (75%), epilepsy (35%), and intellectual disability (49%). 1
Key Clinical Features by Motor Type
- Spastic CP (85-91%): Classified topographically as:
- Hemiplegia (unilateral, 38%)
- Diplegia (lower limbs > upper limbs, 37%)
- Quadriplegia (all 4 limbs and trunk, 24%)
- Dyskinetic (4-7%): Includes dystonia and athetosis, typically affects all 4 limbs
- Ataxic (4-6%): Usually affects all 4 limbs
- Hypotonic (2%): Generalized low tone 1
Critical Comorbidities to Screen For
The functional assessment must include screening for:
- Chronic pain (75% prevalence)
- Epilepsy (35%)
- Intellectual disability (49%)
- Musculoskeletal problems including hip displacement (28%)
- Behavioral disorders (26%)
- Sleep disorders (23%)
- Functional blindness (11%)
- Hearing impairment (4%) 1
Diagnostic Confirmation
Brain MRI is the preferred neuroimaging modality for suspected cerebral palsy (86-89% sensitivity), though diagnosis remains clinical based on history and examination findings 1. The American Academy of Neurology recommends brain imaging for patients suspected of having cerebral palsy 2.
Muscular Dystrophy: Signs and Diagnostic Testing
Suspect Duchenne muscular dystrophy (DMD) in any male child with delayed walking beyond 16-18 months, Gowers' sign (especially <5 years), frequent falls, difficulty running/climbing stairs, or unexplained elevated transaminases; immediately check serum creatine kinase which will be markedly elevated (often >3× normal), then proceed to dystrophin deletion/duplication testing as first-line genetic testing. 3
When to Suspect DMD
Three primary triggers for suspicion:
- Abnormal muscle function in a male child (most common)
- Elevated serum creatine kinase on incidental testing
- Elevated transaminases (AST/ALT) - muscle produces these enzymes; consider DMD before liver biopsy in any male child with elevated transaminases 3
Initial Clinical Presentation
- Delayed walking (not walking by >16-18 months)
- Frequent falls
- Difficulty running and climbing stairs
- Waddling gait
- Toe walking (present but not diagnostically helpful)
- Typical diagnosis age: ~5 years, though can be suspected earlier with developmental delays 3
Diagnostic Algorithm
Step 1: Creatine Kinase Screening
- Markedly increased CK concentrations confirm muscle destruction 3
- CK >3× normal is a red flag requiring prompt referral 2
Step 2: Genetic Testing (First-Line)
- Dystrophin deletion/duplication testing (multiplex ligation-dependent probe amplification or PCR)
- If deletion/duplication found → diagnosis confirmed
- If negative → proceed to dystrophin gene sequencing for point mutations or small deletions/insertions 3
Step 3: Muscle Biopsy (When Indicated)
- Optional if genetic testing confirms diagnosis
- Necessary if genetic testing negative but clinical suspicion high
- Shows absent dystrophin protein on immunocytochemistry/immunoblotting
- Even if diagnosed by muscle biopsy, genetic testing is still necessary for genetic counseling and future mutation-specific therapies 3
Post-Diagnosis Management Priorities
Immediate referrals needed:
- Specialized multidisciplinary follow-up
- Genetic counseling for at-risk female family members
- Patient/family support and patient organizations 3
Surveillance requirements:
- Cardiac: Echocardiogram at diagnosis or by age 6 years; maximum 24 months between studies until age 10, then annually thereafter 3
- Respiratory: Progressive monitoring as respiratory complications are second leading cause of death after cardiac failure 4
- Corticosteroids: Routinely recommended from young age to slow muscle function decline, prolong ambulation, and delay respiratory decline 4
Gowers' Sign
Gowers' sign—a child using hands to "climb up" their own body when rising from the floor—should trigger immediate diagnostic investigation for DMD in any male child, especially if <5 years old, even with normal muscle examination, as DMD cannot be completely excluded by normal exam in children <5 years. 3
Clinical Significance
- Pathognomonic for proximal muscle weakness, particularly hip extensors and quadriceps
- In males, especially concerning for DMD when accompanied by waddling gait
- Should prompt immediate CK testing regardless of family history 3
Age-Related Interpretation
- <5 years: Normal muscle exam does NOT exclude DMD; maintain high suspicion
- Increasing age: Normal muscle exam progressively reduces DMD likelihood
- >10 years: Normal muscle function makes DMD highly unlikely 3
Atlantoaxial Instability in Down Syndrome
Screen children with Down syndrome for atlantoaxial instability (AAI) only when they develop clinical symptoms suggestive of cervical spine pathology (neck pain, torticollis, gait changes, weakness, hyperreflexia, bowel/bladder dysfunction) rather than routine asymptomatic radiographic screening, per 2011 AAP guidelines; however, obtain initial surveillance radiographs for all children >3 years, and continue repeat surveillance in those with os odontoideum given their 71% instability risk. 5, 6
Epidemiology and Risk
- AAI incidence significantly higher in Down syndrome than general population
- Overall AAI rate: 4.4% in pediatric Down syndrome patients
- Os odontoideum present in 71% of unstable spines vs. 2% of stable spines (P<0.0001) 6
- Progression to instability: 1.6% over ~4 years (1 in 23 risk) 6
Clinical Presentation
Neurological symptoms more common in Down syndrome AAI:
- 80% of Down syndrome patients with AAI have neurological symptoms vs. 16.7% in non-Down syndrome controls (P<0.05)
- Os odontoideum more common (66.7% in Down syndrome)
- High-signal area on MRI in 60% of Down syndrome AAI patients 7
Screening Recommendations
Initial screening:
- Obtain cervical spine radiographs for all children >3 years with Down syndrome
- Measure atlantodental interval (ADI) and space available for cord (SAC)
- AAI defined as ADI ≥6 mm or SAC ≤14 mm 6
Repeat surveillance:
- Continue surveillance only in patients with os odontoideum (high instability risk)
- No specific age cut-off or time period after which risk eliminated
- Routine asymptomatic screening not sufficiently predictive for most patients 5, 6
Red Flag Symptoms Requiring Immediate Imaging
- Neck pain (even without significant trauma)
- Torticollis
- Gait changes or difficulty walking
- Upper or lower extremity weakness
- Hyperreflexia
- Bowel or bladder dysfunction
- Neurological deterioration 7, 5
Surgical Considerations
When AAI with neurological symptoms present:
- Posterior atlantoaxial screw-rod fixation and fusion is standard treatment
- Results in good fusion and neurological recovery
- Preoperative ADI typically larger in Down syndrome (9.0 vs. 7.4 mm, P<0.01)
- Solid fusion achieved in all patients with appropriate surgical management 7
Pediatric Airway Anatomy and Obstruction Risk
Children have anatomically narrower airways with the narrowest point at the cricoid ring (vs. vocal cords in adults), larger tongue relative to oral cavity, more anterior and cephalad larynx (C3-4 vs. C4-5), and shorter, more compliant trachea—all increasing obstruction and hypoxia risk, particularly in neuromuscular disease where respiratory muscle weakness compounds anatomical vulnerability. 4
Anatomical Differences Increasing Risk
Structural factors:
- Narrowest point at cricoid ring (subglottic region) vs. glottis in adults
- Proportionally larger tongue and smaller oral cavity
- More anterior and cephalad larynx position (C3-4 level vs. C4-5 in adults)
- Shorter, more compliant trachea prone to dynamic collapse
- Larger occiput causing neck flexion when supine
Functional implications:
- Smaller absolute airway diameter → greater resistance (resistance inversely proportional to radius⁴)
- 1 mm edema in infant airway reduces cross-sectional area by 50-75% vs. 20% in adults
- More compliant chest wall with less efficient respiratory mechanics
- Higher metabolic rate and oxygen consumption
Neuromuscular Disease-Specific Risks
In DMD and other neuromuscular disorders, airway obstruction risk dramatically increases due to:
Respiratory Muscle Weakness
- Inspiratory muscle weakness → nocturnal hypoventilation and sleep-disordered breathing
- Expiratory muscle weakness → poor cough, inability to clear secretions
- Progressive intercostal and diaphragm weakness after loss of ambulation 4
Consequences of Untreated Weakness
- Respiratory failure
- Pneumonia
- Respiratory complications are second leading cause of death in DMD (after cardiac failure)
- Major cause of morbidity and unplanned hospital admission 4
Cardiac-Respiratory Interaction
- Progressive dilated cardiomyopathy affects respiratory function
- Respiratory failure can trigger cardiac arrhythmias or exacerbate cardiac failure
- Requires coordinated cardiac and respiratory management 4
Management Priorities in Neuromuscular Disease
Secretion management:
- Regular lung volume recruitment (breath stacking) with handheld resuscitation bag or mouthpiece
- Mechanical insufflation-exsufflation (cough assist device) when alternative techniques inadequate
- High-frequency chest wall oscillation combined with airway clearance therapies 8
Ventilatory support:
- Monitor for nocturnal hypoventilation and sleep-disordered breathing
- Ventilatory support frequently required after loss of ambulation
- Initially overnight, may progress to 24-hour requirement 4
Musculoskeletal and Orthopedic Complications
The most frequently encountered musculoskeletal complications in children with neuromuscular disorders are scoliosis, bony rotational deformities, and hip dysplasia, which are shared outcomes across diverse neuromuscular etiologies including cerebral palsy, spinal cord injury, spinal muscular atrophy, and muscular dystrophies; close surveillance is essential to identify risk factors early for intervention before progression. 9
Common Complications Across Neuromuscular Disorders
Scoliosis
- Most common orthopedic complication
- Progressive with growth and loss of ambulation
- Can compromise respiratory function when severe
- May require bracing or surgical intervention
Hip Dysplasia and Displacement
- 28% prevalence in cerebral palsy 1
- Results from muscle imbalance and spasticity
- Can cause pain and limit positioning/seating
- Requires regular surveillance with clinical exam and radiographs
Bony Rotational Deformities
- Femoral anteversion, tibial torsion common
- Affect gait mechanics and function
- May require surgical correction in severe cases
Contractures
- Tendo-Achilles contractures particularly common in DMD
- Preventive measures to maintain muscle extensibility essential
- Surgical options considered in certain situations for wheelchair positioning 3
Cerebral Palsy-Specific Manifestations
Comprehensive musculoskeletal assessment includes:
- Poor muscle function and selective motor control
- Spasticity and rigidity
- Muscle weakness
- Soft-tissue and joint contractures
- Torsional malalignments
- Lever arm dysfunctions 10
High risk of progression: Children with CP are at high risk of worsening musculoskeletal abnormalities with natural disease course, requiring close surveillance and early intervention 10.
DMD-Specific Orthopedic Management
Rehabilitation priorities:
- Education and support
- Preventive measures to maintain muscle extensibility and minimize contracture
- Encouragement of appropriate exercise/activity
- Support for function and participation
- Provision of adaptive devices as appropriate 3
Surgical considerations:
- Orthopedic surgery rarely necessary in DMD
- Consider surgical options for tendo-Achilles contractures in specific situations
- Possible intervention for foot positioning to optimize wheelchair positioning 3
Surveillance Strategy
Requires combination of:
- Detailed medical history
- Functional assessment
- Clinical examination
- Gait analysis when applicable
- Radiological assessment
- Regular monitoring to identify progression risk factors 10
Goal: Early identification and intervention to prevent progression and optimize function, mobility, and quality of life.